Use and outcome of 1,220 primary total elbow arthroplasties from the Australian Orthopaedic Association National Joint Arthroplasty Replacement Registry 2008–2018

Jetske Viveen, Michel P.J. van den Bekerom, Job N. Doornberg, Alesha Hatton, Richard Page, Koen L.M. Koenraadt, Christopher Wilson, Gregory I. Bain, Ruurd L. Jaarsma, Denise Eygendaal

Research output: Contribution to journalArticle

Abstract

Background and purpose — The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) was analyzed to determine trends in use of primary total elbow arthroplasty (TEA), the types of prostheses used, primary diagnoses, reasons for and types of revision, and whether the primary diagnosis or prosthesis design influenced the revision rate. Patients and methods — During 2008–2018, 1,220 primary TEA procedures were reported of which 140 TEAs were revised. Kaplan–Meier estimates of survivorship were used to describe the time to first revision and hazard ratios (HR) from Cox proportional hazard models, adjusted for age and sex, were used to compare revision rates. Results — The annual number of TEAs performed remained constant. The 3 most common diagnoses for primary TEA were fracture/dislocation (trauma) (36%), osteoarthritis (OA) (34%), and rheumatoid arthritis (RA) (26%). The cumulative percentage revision for all TEAs undertaken for any reason was 10%, 15%, and 19% at 3, 6, and 9 years. TEAs undertaken for OA had a higher revision rate compared with TEAs for trauma (HR = 1.8, 95% CI 1.1–3.0) and RA (HR = 2.0, CI 1.3–3.1). The Coonrad-Morrey (50%), Latitude (30%), Nexel (10%), and Discovery (9%) were the most used prosthesis designs. There was no difference in revision rates when these 4 designs were compared. The most common reasons for revision were infection (35%) and aseptic loosening (34%). Interpretation — The indications for primary and revision TEA in Australia are similar to those reported for other registries. Revision for trauma is lower than previously reported.

LanguageEnglish
Pages511-516
Number of pages6
JournalActa Orthopaedica
Volume90
Issue number6
DOIs
Publication statusPublished - 27 Sep 2019

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Viveen, Jetske ; van den Bekerom, Michel P.J. ; Doornberg, Job N. ; Hatton, Alesha ; Page, Richard ; Koenraadt, Koen L.M. ; Wilson, Christopher ; Bain, Gregory I. ; Jaarsma, Ruurd L. ; Eygendaal, Denise. / Use and outcome of 1,220 primary total elbow arthroplasties from the Australian Orthopaedic Association National Joint Arthroplasty Replacement Registry 2008–2018. In: Acta Orthopaedica. 2019 ; Vol. 90, No. 6. pp. 511-516.
@article{8825bc1fb710409da1b95168976e6e5e,
title = "Use and outcome of 1,220 primary total elbow arthroplasties from the Australian Orthopaedic Association National Joint Arthroplasty Replacement Registry 2008–2018",
abstract = "Background and purpose — The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) was analyzed to determine trends in use of primary total elbow arthroplasty (TEA), the types of prostheses used, primary diagnoses, reasons for and types of revision, and whether the primary diagnosis or prosthesis design influenced the revision rate. Patients and methods — During 2008–2018, 1,220 primary TEA procedures were reported of which 140 TEAs were revised. Kaplan–Meier estimates of survivorship were used to describe the time to first revision and hazard ratios (HR) from Cox proportional hazard models, adjusted for age and sex, were used to compare revision rates. Results — The annual number of TEAs performed remained constant. The 3 most common diagnoses for primary TEA were fracture/dislocation (trauma) (36{\%}), osteoarthritis (OA) (34{\%}), and rheumatoid arthritis (RA) (26{\%}). The cumulative percentage revision for all TEAs undertaken for any reason was 10{\%}, 15{\%}, and 19{\%} at 3, 6, and 9 years. TEAs undertaken for OA had a higher revision rate compared with TEAs for trauma (HR = 1.8, 95{\%} CI 1.1–3.0) and RA (HR = 2.0, CI 1.3–3.1). The Coonrad-Morrey (50{\%}), Latitude (30{\%}), Nexel (10{\%}), and Discovery (9{\%}) were the most used prosthesis designs. There was no difference in revision rates when these 4 designs were compared. The most common reasons for revision were infection (35{\%}) and aseptic loosening (34{\%}). Interpretation — The indications for primary and revision TEA in Australia are similar to those reported for other registries. Revision for trauma is lower than previously reported.",
author = "Jetske Viveen and {van den Bekerom}, {Michel P.J.} and Doornberg, {Job N.} and Alesha Hatton and Richard Page and Koenraadt, {Koen L.M.} and Christopher Wilson and Bain, {Gregory I.} and Jaarsma, {Ruurd L.} and Denise Eygendaal",
year = "2019",
month = "9",
day = "27",
doi = "10.1080/17453674.2019.1657342",
language = "English",
volume = "90",
pages = "511--516",
journal = "Acta Orthopaedica",
issn = "1745-3674",
publisher = "Informa Healthcare",
number = "6",

}

Viveen, J, van den Bekerom, MPJ, Doornberg, JN, Hatton, A, Page, R, Koenraadt, KLM, Wilson, C, Bain, GI, Jaarsma, RL & Eygendaal, D 2019, 'Use and outcome of 1,220 primary total elbow arthroplasties from the Australian Orthopaedic Association National Joint Arthroplasty Replacement Registry 2008–2018', Acta Orthopaedica, vol. 90, no. 6, pp. 511-516. https://doi.org/10.1080/17453674.2019.1657342

Use and outcome of 1,220 primary total elbow arthroplasties from the Australian Orthopaedic Association National Joint Arthroplasty Replacement Registry 2008–2018. / Viveen, Jetske; van den Bekerom, Michel P.J.; Doornberg, Job N.; Hatton, Alesha; Page, Richard; Koenraadt, Koen L.M.; Wilson, Christopher; Bain, Gregory I.; Jaarsma, Ruurd L.; Eygendaal, Denise.

In: Acta Orthopaedica, Vol. 90, No. 6, 27.09.2019, p. 511-516.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use and outcome of 1,220 primary total elbow arthroplasties from the Australian Orthopaedic Association National Joint Arthroplasty Replacement Registry 2008–2018

AU - Viveen, Jetske

AU - van den Bekerom, Michel P.J.

AU - Doornberg, Job N.

AU - Hatton, Alesha

AU - Page, Richard

AU - Koenraadt, Koen L.M.

AU - Wilson, Christopher

AU - Bain, Gregory I.

AU - Jaarsma, Ruurd L.

AU - Eygendaal, Denise

PY - 2019/9/27

Y1 - 2019/9/27

N2 - Background and purpose — The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) was analyzed to determine trends in use of primary total elbow arthroplasty (TEA), the types of prostheses used, primary diagnoses, reasons for and types of revision, and whether the primary diagnosis or prosthesis design influenced the revision rate. Patients and methods — During 2008–2018, 1,220 primary TEA procedures were reported of which 140 TEAs were revised. Kaplan–Meier estimates of survivorship were used to describe the time to first revision and hazard ratios (HR) from Cox proportional hazard models, adjusted for age and sex, were used to compare revision rates. Results — The annual number of TEAs performed remained constant. The 3 most common diagnoses for primary TEA were fracture/dislocation (trauma) (36%), osteoarthritis (OA) (34%), and rheumatoid arthritis (RA) (26%). The cumulative percentage revision for all TEAs undertaken for any reason was 10%, 15%, and 19% at 3, 6, and 9 years. TEAs undertaken for OA had a higher revision rate compared with TEAs for trauma (HR = 1.8, 95% CI 1.1–3.0) and RA (HR = 2.0, CI 1.3–3.1). The Coonrad-Morrey (50%), Latitude (30%), Nexel (10%), and Discovery (9%) were the most used prosthesis designs. There was no difference in revision rates when these 4 designs were compared. The most common reasons for revision were infection (35%) and aseptic loosening (34%). Interpretation — The indications for primary and revision TEA in Australia are similar to those reported for other registries. Revision for trauma is lower than previously reported.

AB - Background and purpose — The Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) was analyzed to determine trends in use of primary total elbow arthroplasty (TEA), the types of prostheses used, primary diagnoses, reasons for and types of revision, and whether the primary diagnosis or prosthesis design influenced the revision rate. Patients and methods — During 2008–2018, 1,220 primary TEA procedures were reported of which 140 TEAs were revised. Kaplan–Meier estimates of survivorship were used to describe the time to first revision and hazard ratios (HR) from Cox proportional hazard models, adjusted for age and sex, were used to compare revision rates. Results — The annual number of TEAs performed remained constant. The 3 most common diagnoses for primary TEA were fracture/dislocation (trauma) (36%), osteoarthritis (OA) (34%), and rheumatoid arthritis (RA) (26%). The cumulative percentage revision for all TEAs undertaken for any reason was 10%, 15%, and 19% at 3, 6, and 9 years. TEAs undertaken for OA had a higher revision rate compared with TEAs for trauma (HR = 1.8, 95% CI 1.1–3.0) and RA (HR = 2.0, CI 1.3–3.1). The Coonrad-Morrey (50%), Latitude (30%), Nexel (10%), and Discovery (9%) were the most used prosthesis designs. There was no difference in revision rates when these 4 designs were compared. The most common reasons for revision were infection (35%) and aseptic loosening (34%). Interpretation — The indications for primary and revision TEA in Australia are similar to those reported for other registries. Revision for trauma is lower than previously reported.

UR - http://www.scopus.com/inward/record.url?scp=85071172270&partnerID=8YFLogxK

U2 - 10.1080/17453674.2019.1657342

DO - 10.1080/17453674.2019.1657342

M3 - Article

VL - 90

SP - 511

EP - 516

JO - Acta Orthopaedica

T2 - Acta Orthopaedica

JF - Acta Orthopaedica

SN - 1745-3674

IS - 6

ER -